Filters

Anti-CMTM1 Antibody

Anti-CMTM1 Antibody size: 100 μg 514

Supplier ABBEX
Price 514
Size 100 μg
CategoryPrimary Antibodies
Antibody's targetCMTM1
ImmunogenSee techfile
ClonalityPolyclonal
The antibody was raised inRabbit
Reactivity Mouse, Rat, Human
PurificationAffinity purified
ApplicationsWB (for other see techfile or inquire)
Stock availabilityShipped within 25 days
Storage conditions Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C
WarningsThis product is for research use only
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by abbex they should be stored frozen at - 24°
Gene targetCMTM1
Short nameAnti-CMTM1 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameantibody to-chemokine-like factor-like MARVEL transmembrane domain containing 1 (Antibody to)
Alternative techniqueantibodies
Alternative to gene target CMTM1 and IDBG-35133 and ENSG00000089505 and 113540, Cmtm1 and IDBG-185323 and ENSMUSG00000031876 and 100504164, Extracellular, cytokine activity, this GO :0005125 and cytokine activity and molecular function this GO :0005615 and extracellular space and cellular component this GO :0006935 and chemotaxis and biological process this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component, this GO :0005125: cytokine activity, this GO :0005125: cytokine activity, CKLF-like MARVEL transmembrane domain containing 1
Identity 19172
Gene CMTM1
Long gene name CKLF like MARVEL transmembrane domain containing 1
Synonyms gene CKLFSF1
Synonyms gene name chemokine-like factor super family 1 chemokine-like factor superfamily 1 CKLF-like MARVEL transmembrane domain containing 1
Synonyms CKLFH1a CKLFH
Locus 16q21
Discovery year 2002-09-10
GenBank acession AF278577
Entrez gene record 113540
Pubmed identfication 12782130
RefSeq identity NM_052999
Classification CKLF like MARVEL transmembrane domain containing
Havana BLAST/BLAT OTTHUMG00000137502

Subscribe to our Newsletter